Загрузка...
Beyond Peptides and mAbs - Current Status and Future Perspectives for Biotherapeutics with Novel Constructs
Biotherapeutics are attractive anti-cancer agents due to their high specificity and limited toxicity compared to conventional small molecules. Antibodies are widely used in cancer therapy, either directly or conjugated to a cytotoxic payload. Peptide therapies, though not as prevalent, have been uti...
Сохранить в:
| Опубликовано в: : | J Clin Pharmacol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4340091/ https://ncbi.nlm.nih.gov/pubmed/25707963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.407 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|